Loading provider…
Loading provider…
Psychiatry Physician in Gainesville, FL
NPI: 1558477752Primary Practice Location
North Florida Regional Psychiatry, LLC
6800 NW 9th Blvd, Gainesville, FL
Primary Employer
North Florida Regional Psychiatry, LLC
hcahealthcare.com
HQ Phone
Get M.D. Michael's Phone Numberphone_androidMobile
Get M.D. Michael's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
FL State Medical License
1987 - 2026
SC State Medical License
1990 - 2003
CO State Medical License
1989 - 1991

American Board of Psychiatry and Neurology
Psychiatry
Yale School of Medicine
medicine.yale.edu
Medical School
Until 1985
University of Colorado
Residency • Psychiatry
1985 - 1989
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 151 | 315 |
| 2 | 99204New patient office or other outpatient visit, 45-59 minutes | 29 | 29 |
Paroxetine for social anxiety and alcohol use in dual-diagnosed patients.
Authors: Jonathan Davidson
Journal: Depress Anxiety
Somatic symptoms in generalized anxiety disorder with and without comorbid psychiatric disorders.
Authors: Brawman-Mintzer, O, Lydiard, R B, Crawford, M M, Emmanuel, N, Payeur, R, Johnson, M, Knapp, R G, Ballenger, J C
Journal: Am J Psychiatry
Plasma pyridoxal phosphate in anxiety disorders.
Authors: Emmanuel, N P, Lydiard, R B, Reynolds, R D, Roberts, J, Johnson, M, Mintzer, O, Ballenger, J C
Journal: Biol Psychiatry
Lead Sponsor: Rhodes Pharmaceuticals, L.P.
Collaborators: Purdue Pharma LP
Intervention / Treatment: DRUG: PRC-063, DRUG: Drug: PRC-063
Lead Sponsor: Rhodes Pharmaceuticals, L.P.
Collaborators: Purdue Pharma LP
Intervention / Treatment: DRUG: Placebo, DRUG: PRC-063 85 mg, DRUG: PRC-063 25 mg, DRUG: PRC-063 45 mg, DRUG: PRC-063 70 mg
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: Galcanezumab